VIVEX Biologics


VIVEX is dedicated to developing and delivering innovative allografts and regenerative product solutions to help patients suffering from musculoskeletal injuries, wounds, and burned skin. With a history dating back to 1970, VIVEX has experienced multiple firsts in clinical and scientific achievements, focusing on new product development, research, manufacturing, and marketing efforts. The company processes, stores, and distributes human cells, tissues, and cellular and tissue-based products in compliance with FDA and AATB standards, aiming to improve patient outcomes and quality of life.

Industries

biotechnology
health-care
therapeutics

Nr. of Employees

large (251-1000)

VIVEX Biologics

Miami, Florida, United States, North America


Products

Amniotic membrane allografts (single-, dual-, multi-layer, disk, umbilical-derived)

Dehydrated and processed amniotic membrane grafts in multiple configurations and thicknesses intended for wound care and surgical soft-tissue barrier applications; preserved extracellular matrix and signaling proteins; ambient storage with multi-year shelf life.

Demineralized bone matrix (DBM) products (putty, paste, sponge, strip, fibers)

Series of DBM-based bone graft substitutes and extenders provided as pre-mixed putties, syringes, sponges, strips and fiber formulations with osteoconductive and osteoinductive potential and validated handling properties.

Viable allogeneic bone matrices (cryopreserved microparticulate grafts)

Cryopreserved viable bone matrices composed of optimized bone microparticulate and mineralized/cancellous components, intended to support osteoconductive, osteoinductive and osteogenic healing; stored frozen with DMSO-free cryoprotectant.

Moldable composite bone graft substitutes (bioactive strips and putties)

Moldable bioactive scaffolds combining carbonate apatite/anorganic bone mineral, 45S5 bioactive glass and Type I collagen designed for bony ingrowth, moldability upon hydration, and use as graft extenders or bone void fillers.

Demineralized bone fibers and moldable fiber-based scaffolds

Lyophilized demineralized cortical bone fibers supplied in ready-to-use containers that rehydrate quickly and can be molded into desired shapes for bone remodeling applications.

Nucleus pulposus particulate for disc supplementation (injectable)

Processed nucleus pulposus particulate intended to supplement degenerated intervertebral discs, delivered via minimally invasive closed-system mixing and injection through small-gauge needles.


Services

Distributor partnership and portal access

Management of distributor relationships, application/request access to a distributor portal, and national distribution of allograft products to hospitals and approved resellers.

Legacy donor recovery partnership services

Partnerships with accredited recovery organizations to perform tissue recoveries using aseptic surgical techniques and cleanroom protocols, supporting donor acquisition and recovery logistics.

Research & development and product development services

Internal R&D capabilities for development of new allografts, manufacturing enhancements, and translational studies including bench and preclinical work.

Expertise Areas

  • Tissue banking and HCT/P manufacturing
  • Allograft manufacturing for orthopedics and spine
  • Amniotic membrane therapies and wound care
  • Demineralized bone matrix and bone graft substitutes
  • Show More (4)

Key Technologies

  • Amniotic membrane processing and preservation
  • Demineralized bone matrix (DBM) formulation
  • Viable bone matrix cryopreservation (DMSO-free cryoprotectant)
  • Lyophilization (freeze-drying)
  • Show More (9)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.